Values First Advisors, Inc. Recursion Pharmaceuticals, Inc. Transaction History
Values First Advisors, Inc.
- $181 Million
- Q4 2025
A detailed history of Values First Advisors, Inc. transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Values First Advisors, Inc. holds 72,193 shares of RXRX stock, worth $298,879. This represents 0.16% of its overall portfolio holdings.
Number of Shares
72,193
Previous 89,215
19.08%
Holding current value
$298,879
Previous $435,000
31.49%
% of portfolio
0.16%
Previous 0.24%
Shares
12 transactions
Others Institutions Holding RXRX
# of Institutions
355Shares Held
305MCall Options Held
7.56MPut Options Held
4.85M-
Vanguard Group Inc Valley Forge, PA47.2MShares$195 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl33.5MShares$139 Million1.15% of portfolio
-
Baillie Gifford & CO23.8MShares$98.4 Million0.09% of portfolio
-
State Street Corp Boston, MA18.3MShares$75.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$71.7 Million0.0% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $747M
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...